Traws Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 17
- Market Cap
- -
- Website
- http://www.trawspharma.com
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Phase 1
Completed
- Conditions
- Chronic Lymphocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelocytic LeukemiaAcute Myelocytic LeukemiaMyelodysplastic Syndromes
- Interventions
- Drug: ON 01910.Na
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Traws Pharma, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00854646
- Locations
- 🇺🇸
Mount Sinai Medical Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath